Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.49B | 2.61B | 2.45B | 2.45B | 2.09B |
Gross Profit | 943.92M | 1.03B | 938.49M | 896.61M | 753.67M |
EBITDA | 398.47M | 487.13M | 391.53M | 425.56M | 269.36M |
Net Income | 355.98M | 327.01M | 242.93M | 340.41M | 156.57M |
Balance Sheet | |||||
Total Assets | 5.03B | 5.18B | 4.52B | 4.65B | 4.00B |
Cash, Cash Equivalents and Short-Term Investments | 1.95B | 2.27B | 1.98B | 2.21B | 1.68B |
Total Debt | 3.74M | 14.06M | 64.38M | 174.70M | 185.02M |
Total Liabilities | 1.17B | 1.51B | 1.10B | 1.37B | 1.01B |
Stockholders Equity | 3.86B | 3.67B | 3.42B | 3.27B | 3.00B |
Cash Flow | |||||
Free Cash Flow | -150.93M | 267.56M | -131.56M | 603.78M | 617.51M |
Operating Cash Flow | 153.13M | 398.87M | -105.44M | 658.53M | 646.11M |
Investing Cash Flow | -374.62M | 89.34M | 23.86M | -66.30M | -28.40M |
Financing Cash Flow | -159.20M | -146.10M | -226.09M | -71.91M | 54.69M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥2.57B | 7.21 | 3.17% | -4.81% | 8.87% | ||
78 Outperform | ¥2.54B | 4.42 | 2.72% | 23.69% | 173.20% | ||
73 Outperform | ¥11.32B | 6.71 | 1.59% | 20.12% | 17.45% | ||
67 Neutral | £2.85B | 10.49 | 4.46% | 3.55% | 2.44% | -20.00% | |
64 Neutral | ¥2.41B | 64.60 | 2.12% | -23.16% | -83.85% | ||
51 Neutral | ¥3.48B | 23.10 | 1.65% | -19.88% | -203.82% |